xCella is an antibody discovery company based in Menlo Park, California, and built on scientific research from Stanford University and MIT. xCella's xPloration™ platform is a proprietary microcapillary platform that can screen single B cells for specificity and bioactivity and will increase Ligand’s antibody discovery throughput and efficiency. This acquisition also provides Ligand with an existing partnership with Teva Ph...
xCella is an antibody discovery company based in Menlo Park, California, and built on scientific research from Stanford University and MIT. xCella's xPloration™ platform is a proprietary microcapillary platform that can screen single B cells for specificity and bioactivity and will increase Ligand’s antibody discovery throughput and efficiency. This acquisition also provides Ligand with an existing partnership with Teva Pharmaceuticals.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.